Am I correct in thinking that any compound that doesnt act as an agonist at 5ht receptors, such as the aminoindane compounds will ever have potential to explore variations on the mdma "magic" theme? It seems to me like dopamine, ne, and 5ht transporter affinities though definitely have the potential to be euphoric stimulants and psychedelics, alone don't make for a magical entactogen. However since at least one study seems to link the heavy oxytocin release to the euphoric qualities of mdma and the oxytocin release is theorized to be connected to mdma's direct 5ht agonist qualities, the transporter affinity ratios could well not mean a whole lot. I'd guess aet would substitute for mdma in humans more than any aminoindane. I'd guess that any compounds which possess mdma's magic outside of the PEA and Tryptamine structures are a few years away if they exist at all. I'm far from the knowledge level of many on this forum, but it seems to me like the levels of specific receptor affinities as an agonist as opposed to transporter affinities of these compounds are crucial. That doesn't mean they don't have value, but I get the impression many here want to explore variations on that theme of relaxed openness that mdma brings, and I don't know if that's possible with just neurotransmitter releasing agents. If someone who knows more about the subject could speak about this I'd appreciate it.
Also, from what I gather, and again perhaps totally wrong, 5-iai was developed to test for neurotoxicity in the aminoindanes since it is the aminoindane version of the highly nueorotoxic lab standard 4-iodoamphetamine. I thought it wasn't really intended to directly explore the SAR of mdma substituting compounds, even if it does substitute for mbdb.